Johnson & JohnsonvsLeMaitre Vascular

JNJ and LMAT stock compared: price, dividend, valuation and results, from SEC filings.

LMAT

LeMaitre Vascular, Inc.

$75.58

Value $1.7B

-0.68%
LMAT's page

Johnson & Johnson (JNJ) has a market value of $657B and LeMaitre Vascular (LMAT) $1.7B. Over the last year, with dividends, JNJ moved +39.7% and LMAT -12.2%. The P/E is 40.8 for JNJ and 27.2 for LMAT. Dividend yield: JNJ 1.94%, LMAT 1.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$657B

    LMAT$1.7B

    JNJ is 382 times LMAT

  • Revenue, 12 months

    JNJ$99.3B

    LMAT$269M

    JNJ is 369 times LMAT

  • Net income, 12 months

    JNJ$16.1B

    LMAT$63M

    JNJ is 254 times LMAT

  • Operating margin

    JNJ–

    LMAT27.7%

  • ROIC

    JNJ12.4%

    LMAT10.1%

    2.3 points apart

  • P/E

    JNJ40.8

    LMAT27.2

    JNJ is 1.5 times LMAT

  • Dividend yield

    JNJ1.9%

    LMAT1.3%

    0.6 points apart

  • 5-year return

    JNJ+92.0%

    LMAT+48.2%

    43.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+92.0%

LMAT+48.2%

10015020020222023202420252026
Returns by period
PeriodJNJWith dividendsLMATWith dividends
1 year since November 17, 2025+39.7%Price +36.6%-12.2%Price -13.1%
3 years since November 17, 2023+98.2%+25.6% a yearPrice +82.1%+45.9%+13.4% a yearPrice +42.3%
5 years since November 17, 2021+92.0%+13.9% a yearPrice +67.0%+48.2%+8.2% a yearPrice +41.2%
10 years since November 18, 2016+208.0%+11.9% a yearPrice +136.4%+236.7%+12.9% a yearPrice +206.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonLMATLeMaitre Vascular

Valuation

JNJLMAT
Valuation
Price$272.70$75.58
Market value$657B$1.7B
Enterprise value (EV)$685B$1.5B
P/E40.827.2
P/E, 5-year median21.942.4
P/B8.14.0
EV/EBIT38.620.1
Free cash flow yield3.1%3.9%

Results and growth

JNJLMAT
Results and growth
Revenue, 12 months$99.3B$269M
Net income, 12 months$16.1B$63M
Free cash flow, 12 months$20.6B$67M
Earnings per share, 12 months$6.59$2.75
Revenue growth, year on year6.1%13.5%
Revenue growth a year, past+2.7%over 5 years+14.1%over 5 years
EPS growth a year, past+14.9%over 5 years+19.4%over 5 years

Margins and returns on capital

JNJLMAT
Margins and returns on capital
Gross margin67.6%72.0%
Operating margin–27.7%
Net margin16.2%23.5%
ROIC12.4%10.1%
ROE19.7%15.6%

Balance sheet

JNJLMAT
Balance sheet
Cash$17.2B$390M
Total debt$44.7B$189M
Net debt / EBITDA1.1-2.6
Interest cover18.0×14.4×

Dividends and buybacks

JNJLMAT
Dividends and buybacks
Dividend yield1.9%1.3%
Dividend per share, 12 months$5.28$0.95
Dividend growth a year, past+5.3%over 5 years+16.1%over 5 years
Buyback yield0.9%0.1%
Shareholder yield2.9%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or LMAT

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or LeMaitre Vascular?

By market value, Johnson & Johnson ($657B) is about 381.7 times LeMaitre Vascular ($1.7B), at today's prices.

How did JNJ and LMAT stock do over the last 10 years?

Since November 18, 2016, JNJ's price moved +136.4% and LMAT's +206.4%. With dividends: JNJ +208.0% (+11.9% a year), LMAT +236.7% (+12.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or LMAT?

The dividend yield at today's price is 1.94% for Johnson & Johnson and 1.26% for LeMaitre Vascular. Over the last twelve months they paid $5.28 and $0.95 per share.

What is the P/E of JNJ and LMAT?

At today's price, the P/E is 40.8 for JNJ and 27.2 for LMAT. The median of the last five years was 21.9 and 42.4, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or LeMaitre Vascular?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 23.5% for LeMaitre Vascular, and the operating margin – and 27.7%. Revenue was $99.3B and $269M.

Which is the better investment, Johnson & Johnson or LeMaitre Vascular?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.